Skip to main content
OpenTrials

Clinical trial condition

Symptomatic Refractory Resistant Carcinoid Disease

Explore clinical trials studying Symptomatic Refractory Resistant Carcinoid Disease. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Symptomatic Refractory Resistant Carcinoid Disease trial results

Completed

Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease

NCT00690430

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +8 more
Locations
  • Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service Scottsdale, Arizona, United States
  • University of Arizona / Arizona Cancer Center Tucson, Arizona, United States
  • Loma Linda University Dept. of Loma Linda CancerCent Loma Linda, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
View all 62 locations
View Trial Details

Related conditions